First Trust NYSE Arca Biotechnology Index Fund FBT
266.65 USD -12.78 (-4.57%)
Nov 5, 2026, 3:10 PM EST
266.31 Day range 276.76
189.47 52-week range 283.21
- YTD
- +29.11%
- 1 year
- +35.96%
- Market cap
- 1.74B
- EPS (ttm)
- 9.75
- P/E ratio
- 27.36
- YTD return
- +29.11%
- 1-year return
- +35.96%
- Volume
- 73.83K
- Avg volume
- 62.78K
- Open
- 276.60
- Previous close
- 279.42
- Day's range
- 266.31 – 276.76
- 52-week range
- 189.47 – 283.21
YTD +60.91 (+29.32%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 269.27
- 200-day average
- 233.60
Next earnings
Consensus EPS estimate 0.00.
About First Trust NYSE Arca Biotechnology Index Fund
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
News
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? 
ETFs That You May Consider Amid a Strengthening Biotech Outlook 
Which Healthcare ETF Is the Better Buy: Simplify's Mission-Driven PINK or First Trust's Biotech FBT? 
Which Healthcare ETF Is the Better Buy: Invesco’s Broad RSPH or First Trust’s Biotech FBT? 
Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT? 
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH 
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets 
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate 
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? 
Which Is the Better Healthcare ETF: Fidelity's Low-Cost FHLC or First Trust's High-Conviction FBT?
Your note
Sign in to keep a note on FBT — it syncs with the Stock Master app.